Technology
Health
Biotechnology

MorphoSys

$30.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (0.43%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MorphoSys and other stocks, options, ETFs, and crypto commission-free!

About MOR

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. Read More The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

Employees
329
Headquarters
Planegg, Bayern (Bavaria)
Founded
1992
Market Cap
3.80B
Price-Earnings Ratio
Dividend Yield
Average Volume
90.22K
High Today
$30.17
Low Today
$29.83
Open Price
$29.87
Volume
42.85K
52 Week High
$31.96
52 Week Low
$21.75

Collections

Technology
Health
Biotechnology
Research And Development
Therapy
Pharmaceutical
2018 IPO
Europe (Non-UK)

MOR Earnings

-$1.57
-$0.68
$0.20
$1.09
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.213 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.